X-Chem | Latest News & Updates - Dec 20, 2024 Release

X-Chem is currently seeking a Chief Marketing Officer in Latvia...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


X-Chem

🌎 x-chemrx.com

X-Chem is a leading biotechnology research company specializing in small molecule drug discovery. Utilizing DNA-encoded chemical library (DEL) technology, discovery chemistry, and artificial intelligence, X-Chem provides comprehensive solutions for pharmaceutical and biotech companies. With a high success rate in identifying functional hits and a proven track record in various therapeutic targets, X-Chem is dedicated to advancing human health through innovative drug discovery services.


X-Chem - Latest News and Updates

  • X-Chem is currently seeking a Chief Marketing Officer in Latvia.
  • X-Chem is collaborating with Tonix Pharma on the development of the antiviral drug TNX-4200 under a Department of Defense contract worth up to $34 million.
  • In 2024, X-Chem advanced drug discovery with 12 peer-reviewed publications and breakthroughs in synthetic chemistry, covalent drug discovery, and DNA-Encoded Library screening.
  • Waseem Abbas has left X-Chem as a Machine Learning Engineer in the United Kingdom to join GSK as a Software Engineer AI/ML.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.